Daniel Passeri
Chief Executive Officer at CUE BIOPHARMA, INC.
Net worth: 189 755 $ as of 29/04/2024
Daniel Passeri active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CUE BIOPHARMA, INC. | Director/Board Member | 31/07/2016 | - |
| Chief Executive Officer | 31/07/2016 | - | |
| President | 31/07/2016 | 06/10/2019 |
Career history of Daniel Passeri
Former positions of Daniel Passeri
| Companies | Position | Start | End |
|---|---|---|---|
| CURIS, INC. | Director/Board Member | 31/08/2011 | 31/05/2016 |
| Chief Executive Officer | 31/08/2001 | 01/06/2014 | |
| Corporate Officer/Principal | 31/10/2000 | 31/08/2001 | |
| President | 31/08/2001 | 31/01/2013 | |
Genomic Medicine, Inc.
 Genomic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Part of GenoMed, Inc., Genomic Medicine, Inc. is a company that researches and studies disease causing genes. The company is based in St. Louis, MO. Genomic Medicine was acquired by GenoMed, Inc. on November 29, 2001 for $1.25 million. | Corporate Officer/Principal | 30/11/2014 | 31/05/2015 |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Corporate Officer/Principal | 28/02/1997 | 31/10/2000 |
| Boehringer Mannheim Pharmaceuticals Corp. | Corporate Officer/Principal | 28/02/1997 | 28/02/1997 |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Director/Board Member | - | - |
Training of Daniel Passeri
| Imperial College London | Graduate Degree |
| Northeastern University | Undergraduate Degree |
| George Washington University Law School | Graduate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| CUE BIOPHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Health Technology |
Genomic Medicine, Inc.
Genomic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Part of GenoMed, Inc., Genomic Medicine, Inc. is a company that researches and studies disease causing genes. The company is based in St. Louis, MO. Genomic Medicine was acquired by GenoMed, Inc. on November 29, 2001 for $1.25 million. | Commercial Services |
| Boehringer Mannheim Pharmaceuticals Corp. |
- Stock Market
- Insiders
- Daniel Passeri
- Experience
